收藏切换
Establishment of a cell-based screening assay for inhibitors of SARS-CoV-2 3CL protease
收藏切换
PDF
Ling MA, Jian-yuan ZHAO, Sai-sai GUO, Yong-li XIE, Shan CEN*
Acta Pharmaceutica Sinica | 2020, 55(9) : 2122 - 2126
Less
收藏切换
Acta Pharmaceutica Sinica | 2020, 55(9): 2122-2126
Original Articles
Establishment of a cell-based screening assay for inhibitors of SARS-CoV-2 3CL protease
Full
Ling MA, Jian-yuan ZHAO, Sai-sai GUO, Yong-li XIE, Shan CEN*
Affiliations
  • Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences, Beijing 100050, China
Published: 2020-09-12 doi: 10.16438/j.0513-4870.2020-0982
Outline
收藏切换

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the pathogen that caused the global COVID-19 outbreak. The 3C-like protease (3CLpro) of SARS-CoV-2 plays a key role in virus replication and has become an ideal target for antiviral drug design. In this paper, we report the validation and use of bioluminescence resonance energy transfer (BRET) technology to establish a cell-based assay for screening for SARS-CoV-2 virus 3CL protease inhibitors. The results show that the method is able to monitor the cleavage efficiency of 3CL protease with good reproducibility (Z' factor is 0.59), and is consistent with antiviral activity analysis in cell culture. This work demonstrates that this method can be applied to the screening and evaluation of 3CL protease inhibitors, providing a powerful tool for the development of new drugs.

severe acute respiratory syndrome coronavirus 2  /  anti-coronavirus drug  /  screening assay  /  protease
Ling MA, Jian-yuan ZHAO, Sai-sai GUO, Yong-li XIE, Shan CEN. Establishment of a cell-based screening assay for inhibitors of SARS-CoV-2 3CL protease[J]. Acta Pharmaceutica Sinica, 2020 , 55 (9) : 2122 -2126 . DOI: 10.16438/j.0513-4870.2020-0982
Year 2020 volume 55 Issue 9
PDF
126
52
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2020-0982
  • Receive Date:2020-06-14
  • Online Date:2026-01-23
  • Published:2020-09-12
Article Data
Affiliations
History
  • Received:2020-06-14
  • Revised:2020-07-14
Funding
Affiliations
    Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences, Beijing 100050, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2020-0982
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT